HealthDay (10/14, Mundell ) reports parents and physicians “may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts,” but new research “involving more than 54,000 U.S. adolescents found no such link.” Investigators found that children with obesity “who used the drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn’t.” The findings were published in JAMA Pediatrics.
Healio (10/14, Monostra ) reports study results indicate that “adolescents using a GLP-1 were more likely to experience gastrointestinal symptoms…but had lower risk for acute pancreatitis…than the control group.”
Related Links:
— “GLP-1 Weight-Loss Meds Won’t Raise Teens’ Suicide Risk, May Even Lower It,” Ernie Mundell,